Clinical Pharmacology Archives

Publication

Population Pharmacokinetics of Clesrovimab in Preterm and Full-Term Infants

This study, published in Clinical Pharmacology & Therapeutics (CPT), shows how population pharmacokinetic modeling supports…

CertaraFebruary 2, 2026

On-Demand Webinar

Modeling Population PK with Power, Speed, and Ease-of-Use (Phoenix® NLME & Pirana®)

Discover population PK modeling made faster and easier with Phoenix NLME and Pirana in this…

CertaraJanuary 30, 2026

On-Demand Webinar

Regulatory-Trusted Software for Smarter PK/PD Workflows (Phoenix WinNonlin®)

This on demand session demonstrates how Phoenix WinNonlin® and other tools work together within Phoenix®…

CertaraJanuary 27, 2026

Blog

How Model-Informed Drug Development (MIDD) Strengthens Drug Asset Valuation and Answers the Questions Investors Care About Most

Learn how Model-Informed Drug Development strengthens drug asset valuation by reducing uncertainty, predicting clinical performance,…

CertaraJanuary 26, 2026

Webinar

Milliliters, Milligrams, and Moles: Keeping Up with Units in NCA

Danielle PillsburyJanuary 22, 2026

Webinar

Non-compartmental analysis of statin pharmacokinetics in pharmacogenetics research

CertaraJanuary 22, 2026

Webinar

Subcutaneous absorption model

CertaraJanuary 22, 2026

Publication

Combining Aggregate Data and Individual Patient Data in Model-Based Meta-Analysis: An Illustrative Case Study of Tofacitinib in Rheumatoid Arthritis Patients

This article explores how model-based meta-analysis (MBMA) performs when combining aggregate data and individual patient…

CertaraJanuary 22, 2026

On-Demand Webinar

Model-Based Meta-Analysis (MBMA), Quantitative Systems Pharmacology (QSP), and Advanced Modeling in Early Reimbursement Strategy

Watch this on-demand webinar to learn how model-based meta-analysis (MBMA), quantitative systems pharmacology (QSP), and…

CertaraJanuary 22, 2026

Blog

Adaptive clinical trials in oncology: Meeting the challenge of Project Optimus

Leveraging adaptive clinical trial designs in oncology can accelerate drug development, while following the FDA…

CertaraJanuary 16, 2026

Clinical Pharmacology

Population Pharmacokinetics of Clesrovimab in Preterm and Full-Term Infants

Modeling Population PK with Power, Speed, and Ease-of-Use (Phoenix® NLME & Pirana®)

Regulatory-Trusted Software for Smarter PK/PD Workflows (Phoenix WinNonlin®)

How Model-Informed Drug Development (MIDD) Strengthens Drug Asset Valuation and Answers the Questions Investors Care About Most

Milliliters, Milligrams, and Moles: Keeping Up with Units in NCA

Non-compartmental analysis of statin pharmacokinetics in pharmacogenetics research

Subcutaneous absorption model

Combining Aggregate Data and Individual Patient Data in Model-Based Meta-Analysis: An Illustrative Case Study of Tofacitinib in Rheumatoid Arthritis Patients

Model-Based Meta-Analysis (MBMA), Quantitative Systems Pharmacology (QSP), and Advanced Modeling in Early Reimbursement Strategy

Adaptive clinical trials in oncology: Meeting the challenge of Project Optimus

Newsletter sign up

Quick links

Solutions

Contact